Effectiveness of Injectable Alendronat for Bone Defect due to Osteoporosis
Alendronate is a drug of the bisphosphonate group used for the treatment and prevention of osteoporosis in postmenopausal women. However, when given orally, alendronate can cause indigestion and osteonecrosis of the jaw. It also has a poor bioavailability. Taking these disadvantages into account, an...
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Humanistic Network for Science and Technology
2019-01-01
|
| Series: | Health Notions |
| Subjects: | |
| Online Access: | http://heanoti.com/index.php/hn/article/view/291 |